OBJECTIVE: To examine associations of foot symptoms with self-reported and performance-based measures of physical function in a large, biracial, community-based sample of individuals ages ≥45 years. METHODS: Data from 2,589 Johnston County participants (evaluated in 1999-2004) were used in cross-sectional analyses. The presence of foot symptoms was defined as pain, aching, or stiffness of at least one foot on most days. Physical function was assessed by the total Stanford Health Assessment Questionnaire (HAQ) score (0, >0 but <1, and ≥1), timed 5 repeated chair stands (completion time <12 seconds, ≥12 seconds, and unable), and 8-foot walk time (<3.35 seconds and ≥3.35 seconds). Separate multivariable logistic regression models examined associations between foot symptoms and physical function measures, controlling for age, race, sex, body mass index, radiographic knee osteoarthritis, radiographic hip osteoarthritis, knee symptoms, hip symptoms, and depressive symptoms. Interaction terms between each of the 3 physical function measures and each demographic and clinical characteristic were examined. RESULTS: The prevalence of foot symptoms was 37%. Participants with foot symptoms were more likely than those without symptoms to have higher HAQ scores (adjusted odds ratio [OR] 1.79, 95% confidence interval [95% CI] 1.50-2.12). Among obese participants, those with foot symptoms had longer chair stand (adjusted OR 1.38, 95% CI 1.04-1.87) and 8-foot walk times (adjusted OR 1.61, 95% CI 1.21-2.15) than those without symptoms. CONCLUSION: Foot symptoms were independently and significantly associated with 2 of 3 measures of poorer physical function. Interventions for foot symptoms may be important for helping patients prevent or deal with an existing decline in physical function.
OBJECTIVE: To examine associations of foot symptoms with self-reported and performance-based measures of physical function in a large, biracial, community-based sample of individuals ages ≥45 years. METHODS: Data from 2,589 Johnston County participants (evaluated in 1999-2004) were used in cross-sectional analyses. The presence of foot symptoms was defined as pain, aching, or stiffness of at least one foot on most days. Physical function was assessed by the total Stanford Health Assessment Questionnaire (HAQ) score (0, >0 but <1, and ≥1), timed 5 repeated chair stands (completion time <12 seconds, ≥12 seconds, and unable), and 8-foot walk time (<3.35 seconds and ≥3.35 seconds). Separate multivariable logistic regression models examined associations between foot symptoms and physical function measures, controlling for age, race, sex, body mass index, radiographic knee osteoarthritis, radiographic hip osteoarthritis, knee symptoms, hip symptoms, and depressive symptoms. Interaction terms between each of the 3 physical function measures and each demographic and clinical characteristic were examined. RESULTS: The prevalence of foot symptoms was 37%. Participants with foot symptoms were more likely than those without symptoms to have higher HAQ scores (adjusted odds ratio [OR] 1.79, 95% confidence interval [95% CI] 1.50-2.12). Among obeseparticipants, those with foot symptoms had longer chair stand (adjusted OR 1.38, 95% CI 1.04-1.87) and 8-foot walk times (adjusted OR 1.61, 95% CI 1.21-2.15) than those without symptoms. CONCLUSION: Foot symptoms were independently and significantly associated with 2 of 3 measures of poorer physical function. Interventions for foot symptoms may be important for helping patients prevent or deal with an existing decline in physical function.
Authors: Fadi Badlissi; Julie E Dunn; Carol L Link; Julie J Keysor; John B McKinlay; David T Felson Journal: J Am Geriatr Soc Date: 2005-06 Impact factor: 5.562
Authors: Yvonne M Golightly; Robert F Devellis; Amanda E Nelson; Marian T Hannan; L Stefan Lohmander; Jordan B Renner; Joanne M Jordan Journal: Arthritis Care Res (Hoboken) Date: 2014-03 Impact factor: 4.794
Authors: Yvonne M Golightly; Alyssa B Dufour; Marian T Hannan; Howard J Hillstrom; Patricia P Katz; Joanne M Jordan Journal: J Gerontol A Biol Sci Med Sci Date: 2015-08-21 Impact factor: 6.053
Authors: Sharon Bout-Tabaku; Resmi Gupta; Todd M Jenkins; Justin R Ryder; Amy E Baughcum; Rebecca D Jackson; Thomas H Inge; John B Dixon; Michael A Helmrath; Anita P Courcoulas; James E Mitchell; Carroll M Harmon; Changchun Xie; Marc P Michalsky Journal: Pediatrics Date: 2019-11-19 Impact factor: 7.124
Authors: Alyssa B Dufour; Elena Losina; Hylton B Menz; Michael P LaValley; Marian T Hannan Journal: Obes Res Clin Pract Date: 2016-11-22 Impact factor: 2.288
Authors: Smita Rao; K Douglas Gross; Jingbo Niu; Michael C Nevitt; Cora E Lewis; James C Torner; Jean Hietpas; David Felson; Howard J Hillstrom Journal: Arthritis Care Res (Hoboken) Date: 2016-07-27 Impact factor: 4.794
Authors: Sharon Bout-Tabaku; Marc P Michalsky; Todd M Jenkins; Amy Baughcum; Meg H Zeller; Mary L Brandt; Anita Courcoulas; Ralph Buncher; Michael Helmrath; Carroll M Harmon; Mike K Chen; Thomas H Inge Journal: JAMA Pediatr Date: 2015-06 Impact factor: 16.193
Authors: Hylton B Menz; Alyssa B Dufour; Virginia A Casey; Jody L Riskowski; Robert R McLean; Patricia Katz; Marian T Hannan Journal: J Gerontol A Biol Sci Med Sci Date: 2013-05-23 Impact factor: 6.053
Authors: Marian T Hannan; Hylton B Menz; Joanne M Jordan; L Adrienne Cupples; Chia-Ho Cheng; Yi-Hsiang Hsu Journal: Arthritis Care Res (Hoboken) Date: 2013-09 Impact factor: 4.794